Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

PHASE3CompletedINTERVENTIONAL
Enrollment

558

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
Walking ImpairmentMultiple Sclerosis
Interventions
DRUG

ADS-5102, 137 mg

Oral capsules

DRUG

ADS-5102, 274 mg

Oral capsules

OTHER

Placebo

Oral capsules

Trial Locations (84)

10029

Adamas Clinical Site, New York

10306

Adamas Clinical Site, Staten Island

11042

Adamas Clinical Site, Lake Success

11772

Adamas Clinical Site, Patchogue

11803

Adamas Clinical Site, Plainview

14226

Adamas Clinical Site, Amherst

14642

Adamas Clinical Site, Rochester

19140

Adamas Clinical Site, Philadelphia

20007

Adamas Clinical Site, Washington D.C.

23502

Adamas Clinical Site, Norfolk

23601

Adamas Clinical Site, Newport News

27607

Adamas Clinical Site, Raleigh

28207

Adamas Clinical Site, Charlotte

29307

Adamas Clinical Site, Spartanburg

29406

Adamas Clinical Site, Charleston

29650

Adamas Clinical Site, Greer

29707

Adamas Clinical Site, Old Point Station

30309

Adamas Clinical Site, Atlanta

31406

Adamas Clinical Site, Savannah

32164

Adamas Clinical Site, Palm Coast

32174

Adamas Clinical Site, Ormond Beach

32751

Adamas Clinical Site, Maitland

32806

Adamas Clinical Site, Orlando

32960

Adamas Clinical Site, Vero Beach

33136

Adamas Clinical Site, Miami

33609

Adamas Clinical Site, Tampa

33952

Adamas Clinical Site, Port Charlotte

34105

Adamas Clinical Site, Naples

34233

Adamas Clinical Site, Sarasota

35058

Adamas Clinical Site, Cullman

37064

Adamas Clinical Site, Franklin

37604

Adamas Clinical Site, Johnson City

38018

Adamas Clinical Site, Cordova

43214

Adamas Clinical Site, Columbus

44195

Adamas Clinical Site, Cleveland

45459

Adamas Clinical Site, Centerville

46256

Adamas Clinical Site, Indianapolis

48201

Admas Clinical Site, Detroit

48334

Adamas Clinical Site, Farmington Hills

53215

Adamas Clinical Site, Milwaukee

55422

Adamas Clinical Site, Golden Valley

59405

Adamas Clinical Site, Great Falls

60062

Adamas Clinical Site, Northbrook

63110

Adamas Clinical Site, St Louis

64111

Adamas Clinical Site, Kansas City

66160

Adamas Clinical Site, Kansas City

66212

Adamas Clinical Site, Overland Park

66214

Adamas Clinical Site, Lenexa

68198

Adamas Clinical Site, Omaha

68506

Adamas Clinical Site, Lincoln

73104

Adamas Clinical Site, Oklahoma City

77030

Adamas Clinical Site, Houston

77074

Adamas Clinical Site, Houston

78681

Adamas Clinical Site, Round Rock

80045

Adamas Clinical Site, Aurora

80209

Adamas Clinical Site, Denver

80528

Adamas Clinical Site, Fort Collins

80907

Adamas Clinical Site, Colorado Springs

84103

Adamas Clinical Site, Salt Lake City

85032

Adamas Clinical Site, Phoenix

85251

Adamas Clinical Site, Scottsdale

85704

Adamas Clinical Site, Tucson

87131

Adamas Clinical Site, Albuquerque

89016

Adamas Clinical Site, Las Vegas

90806

Adamas Clinical Site, Long Beach

92011

Adamas Clinical Site, Carlsbad

92663

Adamas Clinical Site, Newport Beach

92835

Adamas Clinical Site, Fullerton

93710

Adamas Clinical Site, Fresno

95817

Adamas Clinical Site, Sacramento

97225

Adamas Clinical Site, Portland

98034

Adamas Clinical Site, Kirkland

98101

Adamas Clinical Site, Seattle

98122

Adamas Clinical Site, Seattle

06824

Adamas Clinical Site, Fairfield

06320

Adamas Clinical Site, New London

02035

Adamas Clinical Site, Foxborough

02421

Adamas Clinical Site, Lexington

T6R 2B7

Adamas Clinical Site, Edmonton

T1J 0N9

Adamas Clinical Site, Lethbridge

V5G 2X6

Adamas Clinical Site, Burnaby

J4V 2J2

Adamas Clinical Site, Greenfield Park

H3A 2B4

Adamas Clinical Site, Montreal

G1J 1Z4

Adamas Clinical Site, Québec

Sponsors
All Listed Sponsors
lead

Adamas Pharmaceuticals, Inc.

INDUSTRY

NCT03436199 - Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment | Biotech Hunter | Biotech Hunter